[PTGX] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -0.46%
YoY- -51.47%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 254,953 0 25,722 6,189 3,647 1,560 10,781 69.33%
PBT 210,666 -33,725 -20,930 -23,998 -19,904 -13,920 -7,661 -
Tax 3,326 -2,296 -181 -79 176 183 0 -
NP 207,340 -31,429 -20,749 -23,998 -20,080 -14,103 -7,661 -
Tax Rate -1.58% - - - - - - -
Total Cost 47,613 31,429 46,471 30,187 23,727 15,663 18,442 17.10%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 81.32 0.00 -80.67 -387.75 -550.59 -904.04 -71.06 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS 3.41 -0.62 -0.43 -0.54 -0.72 -0.58 -0.36 -
EPS Diluted 3.26 -0.62 -0.43 -0.54 -0.72 -0.58 -0.36 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.